GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » EV-to-Revenue

Biotech Growth Trust (The) (LSE:BIOG) EV-to-Revenue : -3.67 (As of May. 28, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biotech Growth Trust (The)'s enterprise value is £324.67 Mil. Biotech Growth Trust (The)'s Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was £-88.47 Mil. Therefore, Biotech Growth Trust (The)'s EV-to-Revenue for today is -3.67.

The historical rank and industry rank for Biotech Growth Trust (The)'s EV-to-Revenue or its related term are showing as below:

LSE:BIOG' s EV-to-Revenue Range Over the Past 10 Years
Min: -17.89   Med: 2.54   Max: 23.39
Current: -3.67

During the past 13 years, the highest EV-to-Revenue of Biotech Growth Trust (The) was 23.39. The lowest was -17.89. And the median was 2.54.

LSE:BIOG's EV-to-Revenue is ranked worse than
100% of 1458 companies
in the Asset Management industry
Industry Median: 9.605 vs LSE:BIOG: -3.67

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Biotech Growth Trust (The)'s stock price is £9.48. Biotech Growth Trust (The)'s Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £-2.24. Therefore, Biotech Growth Trust (The)'s PS Ratio for today is .


Biotech Growth Trust (The) EV-to-Revenue Historical Data

The historical data trend for Biotech Growth Trust (The)'s EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) EV-to-Revenue Chart

Biotech Growth Trust (The) Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.53 5.51 2.78 -1.91 -8.52

Biotech Growth Trust (The) Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.91 - -8.52 -

Competitive Comparison of Biotech Growth Trust (The)'s EV-to-Revenue

For the Asset Management subindustry, Biotech Growth Trust (The)'s EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Growth Trust (The)'s EV-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s EV-to-Revenue falls into.



Biotech Growth Trust (The) EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biotech Growth Trust (The)'s EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=324.672/-88.474
=-3.67

Biotech Growth Trust (The)'s current Enterprise Value is £324.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biotech Growth Trust (The)'s Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was £-88.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotech Growth Trust (The)  (LSE:BIOG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biotech Growth Trust (The)'s PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=9.48/-2.243
=

Biotech Growth Trust (The)'s share price for today is £9.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was £-2.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotech Growth Trust (The) EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Growth Trust (The) (LSE:BIOG) Business Description

Traded in Other Exchanges
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines